RT @NEJM: Original Article: Effect of #Aspirin on All-Cause Mortality in the Healthy Elderly (ASPREE) https://t.co/Cn2Ot9f1ka https://t.co/…
RT @NEJM: Original Article: Effect of #Aspirin on All-Cause Mortality in the Healthy Elderly (ASPREE) https://t.co/Cn2Ot9f1ka https://t.co/…
RT @NEJM: Original Article: Effect of #Aspirin on All-Cause Mortality in the Healthy Elderly (ASPREE) https://t.co/Cn2Ot9f1ka https://t.co/…
RT @SNR_RITA_Trial: Aspirin and all cause mortality in the older person…. https://t.co/nsWWslW2QO
A randomized prospective trial finds that daily #aspirin in healthy elderly population increases mortality attributed to #cancer. Un ensayo clínico encuentra que la aspirina en población sana incrementa el riesgo de muerte por cáncer @NEJM https://t.co/Yfs
Evidence to avoid aspirin for #prevention even in elderly
Effect of Aspirin on All-Cause Mortality in the Healthy Elderly | NEJM https://t.co/33nUZ9TwgZ Higher all-cause mortality in the ASA group due to more cancers - unexpected indeed https://t.co/z2XaovqtLH
RT @SBurtey: Prendre de l'aspirine quand on est vieux et en bonne santé augmente la mortalité et le risque de saigner sans aucun bénéfice…
Worrisome - aspirin increased all cause mortality in health older folks!
RT @whyes: 这个研究有些毁三观。大规模(近两万人)的随机对照研究发现,对于相对健康的老年人,每天1粒拜阿司匹林不能提供心血管病方面的益处,反而增加了大出血的风险,并且稍稍增加了死亡率。最接受不了的结果在于,阿司匹林反而增加了癌症相关的死亡率,风险上升30%左右。 ht…
RT @accpcardprn: Primary prevention aspirin has really been taking it on the chin the last few weeks. https://t.co/IK3Isn1k8i
RT @NEJM: Original Article: Effect of #Aspirin on All-Cause Mortality in the Healthy Elderly (ASPREE) https://t.co/Cn2Ot9f1ka https://t.co/…
RT @DrHBurstein: In placebo controlled trial of health older individuals, aspirin use doubled risk of overall death, doubled risk of breast…
RT @canibagthat: How many times have you had a patient who was taking ASA “just in case”? https://t.co/M5RpAeDsnQ
RT @J_C_MD_PhD: Primaire preventie van hart-vaatziekten bij gezonde ouderen door aspirine: geen baat, wel schade. https://t.co/jMb4m0WdR2
Now message is clear! Aspirin is doesn’t disability free survival or reduce cardiovascular events or decrease mortality in asymptotic healthy elderly individuals. Effect of Aspirin on All-Cause Mortality in the Healthy Elderly | NEJM https://t.co/bMRxXWjBI
RT @EstebanDL: Personas sanas mayores de 65 años Aspirina 100 mg vs placebo Aumento de mortalidad en el grupo Aspirina https://t.co/En28bAU…
RT @NEJM: Original Article: Effect of #Aspirin on All-Cause Mortality in the Healthy Elderly (ASPREE) https://t.co/Cn2Ot9f1ka https://t.co/…
RT @HighSTEACS: #ASPREE trial should influence practice. Aspirin in healthy older persons increases all cause mortality (excess cancer deat…
Waoo. This is surprising results. #Aspirin was associated with increased cancer related deaths in large placebo controlled trial on 19000 elderly people. @NEJM
RT @xsaezll: Cuidado con la aspirina diaria: no beneficio, pero si riesgos!!! Effect of Aspirin on All-Cause Mortality in the Healthy Elder…
Higher all-cause mortality was observed among apparently healthy older adults who received daily aspirin than among those who received placebo and was attributed primarily to cancer-related death. It should be interpreted with caution. https://t.co/l4kGReg
Effect of Aspirin on All-Cause Mortality in the Healthy Elderly | NEJM https://t.co/wRGBUDwl0W
How many times have you had a patient who was taking ASA “just in case”?
RT @TKDsosyal: ASCEND, ARRIVE and now ASPREE. In patients w/o CVD, dementia and physical disability daily ASA 100 mg did not ⬇️ comp. prim…
First do no harm. Publicly-funded academic trials again and again show that less is often better to the benefit of patients and society #choosingwise
RT @xsaezll: Cuidado con la aspirina diaria: no beneficio, pero si riesgos!!! Effect of Aspirin on All-Cause Mortality in the Healthy Elder…
Effect of aspirin on all-cause mortality in the healthy elderly: despite reductions in cardiovascular-related deaths, higher all-cause mortality was observed primarily due to increased cancer-related deaths. https://t.co/wjx21ujlG4 https://t.co/78CLLC4hXo
RT @NEJM: Original Article: Effect of #Aspirin on All-Cause Mortality in the Healthy Elderly (ASPREE) https://t.co/Cn2Ot9f1ka https://t.co/…
RT @xsaezll: Cuidado con la aspirina diaria: no beneficio, pero si riesgos!!! Effect of Aspirin on All-Cause Mortality in the Healthy Elder…
RT @NEJM: Original Article: Effect of #Aspirin on All-Cause Mortality in the Healthy Elderly (ASPREE) https://t.co/Cn2Ot9f1ka https://t.co/…
RT @Drlipid: Higher all-cause mortality was observed in apparently healthy older adults who received daily ASA vs placebo & was attributed…
Effect of Aspirin on All-Cause Mortality in the Healthy Elderly | NEJM https://t.co/qC0kqR68d5 #aspirin
RT @NEJM: Original Article: Effect of #Aspirin on All-Cause Mortality in the Healthy Elderly (ASPREE) https://t.co/Cn2Ot9f1ka https://t.co/…
RT @NEJM: Original Article: Effect of #Aspirin on All-Cause Mortality in the Healthy Elderly (ASPREE) https://t.co/Cn2Ot9f1ka https://t.co/…
3) Aspirin use in healthy elderly persons did not prolong disability-free survival over a period of 5 years but led to a higher rate of major hemorrhage than placebo https://t.co/vci8kKTQRk https://t.co/ZUylqTl2wQ https://t.co/F4DKKbjjCW
#ASPREE trial should influence practice. Aspirin in healthy older persons increases all cause mortality (excess cancer deaths) and major haemorrhage with no reduction in major adverse cardiovascular events
Aspirin and all cause mortality in the older person…. https://t.co/nsWWslW2QO
Effect of Aspirin on All-Cause Mortality in the Healthy Elderly | NEJM Not only Bleeding risk but Cancer ! @JPUsdin https://t.co/zZ1IK0HQXx
RT @xsaezll: Cuidado con la aspirina diaria: no beneficio, pero si riesgos!!! Effect of Aspirin on All-Cause Mortality in the Healthy Elder…
Aspirin can kill https://t.co/pWaqDH5VmL
RT @jjkiladjian: 3 études avec absence de bénéfice voire effet délétère de l'aspirine dans la population âgée en général : urgence à complé…
RT @jjkiladjian: 3 études avec absence de bénéfice voire effet délétère de l'aspirine dans la population âgée en général : urgence à complé…
RT @EstebanDL: Personas sanas mayores de 65 años Aspirina 100 mg vs placebo Aumento de mortalidad en el grupo Aspirina https://t.co/En28bAU…
RT @NEJM: Original Article: Effect of #Aspirin on All-Cause Mortality in the Healthy Elderly (ASPREE) https://t.co/Cn2Ot9f1ka https://t.co/…
RT @NEJM: Original Article: Effect of #Aspirin on All-Cause Mortality in the Healthy Elderly (ASPREE) https://t.co/Cn2Ot9f1ka https://t.co/…
More cancer mortality with low dose aspirin than placebo, including colorectal cancer. Hard to understand. Many hypothesis but no clear explanation. Hope McNeil and ASPREE investigators dive deeper in their data. https://t.co/dQQt2w60II
RT @TKDsosyal: ASCEND, ARRIVE and now ASPREE. In patients w/o CVD, dementia and physical disability daily ASA 100 mg did not ⬇️ comp. prim…
To take the daily low dose aspirin or not. Scientists still uncertain if it helps healthy adults or increases cancer risk The conclusion warns results unexpected. ^..^ https://t.co/XvqxWlcvtH
RT @NEJM: Original Article: Effect of #Aspirin on All-Cause Mortality in the Healthy Elderly (ASPREE) https://t.co/Cn2Ot9f1ka https://t.co/…
RT @EstebanDL: Personas sanas mayores de 65 años Aspirina 100 mg vs placebo Aumento de mortalidad en el grupo Aspirina https://t.co/En28bAU…
Scientists and studies are often flawed or inaccurate. The conclusion warns results unexpected even with a large broad study group. ^..^ https://t.co/eu4m0NjJZq
RT @drjasondungu: Very interesting data, suggesting increased mortality risk with Aspirin use related to cancer. In elderly primary prevent…
I never fully subscribed to aspirin being a preventative cure for breast and colorectal. This is a very interesting prospective data study
Effect of #Aspirin on All-Cause #Mortality in the Healthy #Elderly https://t.co/0JRe42ToUf @NEJM #FOAMed #ECM
RT @NEJM: Original Article: Effect of #Aspirin on All-Cause Mortality in the Healthy Elderly (ASPREE) https://t.co/Cn2Ot9f1ka https://t.co/…
RT @NEJM: Original Article: Effect of #Aspirin on All-Cause Mortality in the Healthy Elderly (ASPREE) https://t.co/Cn2Ot9f1ka https://t.co/…
RT @TKDsosyal: ASCEND, ARRIVE and now ASPREE. In patients w/o CVD, dementia and physical disability daily ASA 100 mg did not ⬇️ comp. prim…
ASCEND, ARRIVE and now ASPREE. In patients w/o CVD, dementia and physical disability daily ASA 100 mg did not ⬇️ comp. primary endpoints,⬆️ the risk of major bleeding and ⬆️ all-cause mortality primarily driven by cancer related death.@JohnMcNeil6 https:
RT @NEJM: Original Article: Effect of #Aspirin on All-Cause Mortality in the Healthy Elderly (ASPREE) https://t.co/Cn2Ot9f1ka https://t.co/…
Interesting results that call common practices into question.
RT @NEJM: Original Article: Effect of #Aspirin on All-Cause Mortality in the Healthy Elderly (ASPREE) https://t.co/Cn2Ot9f1ka https://t.co/…
RT @whyes: 这个研究有些毁三观。大规模(近两万人)的随机对照研究发现,对于相对健康的老年人,每天1粒拜阿司匹林不能提供心血管病方面的益处,反而增加了大出血的风险,并且稍稍增加了死亡率。最接受不了的结果在于,阿司匹林反而增加了癌症相关的死亡率,风险上升30%左右。 ht…
RT @abdosurgeon: This is unexpected, difficult to understand the mechanism, but effect size is very small. https://t.co/ghgVlwO9W4
It’s all about aspirin nowadays !!!! after ASCEND and ARRIVE, ASPREE “Aspirin in Reducing Events in the Elderly” trial -https://t.co/2D3JQuLyO2 -https://t.co/hzL8kzbPVN -https://t.co/rvokuo8RKx https://t.co/LdkKDCvoXp
RT @NEJM: Original Article: Effect of #Aspirin on All-Cause Mortality in the Healthy Elderly (ASPREE) https://t.co/Cn2Ot9f1ka https://t.co/…
RT @DrHBurstein: In placebo controlled trial of health older individuals, aspirin use doubled risk of overall death, doubled risk of breast…
RT @DrHBurstein: In placebo controlled trial of health older individuals, aspirin use doubled risk of overall death, doubled risk of breast…
RT @NEJM: Original Article: Effect of #Aspirin on All-Cause Mortality in the Healthy Elderly (ASPREE) https://t.co/Cn2Ot9f1ka https://t.co/…
RT @NEJM: Original Article: Effect of #Aspirin on All-Cause Mortality in the Healthy Elderly (ASPREE) https://t.co/Cn2Ot9f1ka https://t.co/…
The use of ASA in those > 70 did not seem to improve CV death.
RT @NEJM: Original Article: Effect of #Aspirin on All-Cause Mortality in the Healthy Elderly (ASPREE) https://t.co/Cn2Ot9f1ka https://t.co/…
RT @NEJM: Original Article: Effect of #Aspirin on All-Cause Mortality in the Healthy Elderly (ASPREE) https://t.co/Cn2Ot9f1ka https://t.co/…
RT @NEJM: Original Article: Effect of #Aspirin on All-Cause Mortality in the Healthy Elderly (ASPREE) https://t.co/Cn2Ot9f1ka https://t.co/…
RT @NEJM: Original Article: Effect of #Aspirin on All-Cause Mortality in the Healthy Elderly (ASPREE) https://t.co/Cn2Ot9f1ka https://t.co/…
RT @J_C_MD_PhD: Primaire preventie van hart-vaatziekten bij gezonde ouderen door aspirine: geen baat, wel schade. https://t.co/jMb4m0WdR2
RT @NEJM: Original Article: Effect of #Aspirin on All-Cause Mortality in the Healthy Elderly (ASPREE) https://t.co/Cn2Ot9f1ka https://t.co/…
Very interesting data, suggesting increased mortality risk with Aspirin use related to cancer. In elderly primary prevention pts. Effect of Aspirin on All-Cause Mortality in the Healthy Elderly | NEJM https://t.co/9qVPC3hdSU
Interesting, aspirin failed to reduce mortality in otherwise healthy seniors. AND there was increased risk of cancer related death. Hmmm. Effect of Aspirin on All-Cause Mortality in the Healthy Elderly | NEJM https://t.co/putQGd2oxX
RT @NEJM: Original Article: Effect of #Aspirin on All-Cause Mortality in the Healthy Elderly (ASPREE) https://t.co/Cn2Ot9f1ka https://t.co/…
What a dramatic change in outcome compared to all other studies. What has changed?
Effect of Aspirin on All-Cause Mortality in the Healthy Elderly | NEJM https://t.co/K8keggBBJk
RT @jjkiladjian: 3 études avec absence de bénéfice voire effet délétère de l'aspirine dans la population âgée en général : urgence à complé…
RT @NEJM: Original Article: Effect of #Aspirin on All-Cause Mortality in the Healthy Elderly (ASPREE) https://t.co/Cn2Ot9f1ka https://t.co/…
RT @NEJM: Original Article: Effect of #Aspirin on All-Cause Mortality in the Healthy Elderly (ASPREE) https://t.co/Cn2Ot9f1ka https://t.co/…
RT @DrHBurstein: In placebo controlled trial of health older individuals, aspirin use doubled risk of overall death, doubled risk of breast…
RT @aksoysercan: Sağlıklı insanlarda aspirin yaşam süresini uzatmıyor! Aspirin efsanesi sarsılıyor! https://t.co/L0TVDCrSTs
RT @DrHBurstein: In placebo controlled trial of health older individuals, aspirin use doubled risk of overall death, doubled risk of breast…
RT @EstebanDL: Personas sanas mayores de 65 años Aspirina 100 mg vs placebo Aumento de mortalidad en el grupo Aspirina https://t.co/En28bAU…
RT @NEJM: Original Article: Effect of #Aspirin on All-Cause Mortality in the Healthy Elderly (ASPREE) https://t.co/Cn2Ot9f1ka https://t.co/…
RT @EstebanDL: Personas sanas mayores de 65 años Aspirina 100 mg vs placebo Aumento de mortalidad en el grupo Aspirina https://t.co/En28bAU…
In placebo controlled trial of health older individuals, aspirin use doubled risk of overall death, doubled risk of breast cancer death and 77% increased colorectal cancer death. Another prospective blow to retrospective epidemiological data. https://t.co
RT @NEJM: Original Article: Effect of #Aspirin on All-Cause Mortality in the Healthy Elderly (ASPREE) https://t.co/Cn2Ot9f1ka https://t.co/…
RT @jordiquincoces: Un estudio de la #Aspirina relacionada con la mortalidad en la población sana de la tercera edad. #Salud #Medicina http…
This is unexpected, difficult to understand the mechanism, but effect size is very small.
Prendre de l'aspirine quand on est vieux et en bonne santé augmente la mortalité et le risque de saigner sans aucun bénéfice donc l'aspirine en prévention primaire on le prend et on le fout à la poubelle sans angoisse. #ASPREE https://t.co/u03DywdmEm